510 Pharmacokinetics (PK) and effects on irinotecan (CPT-11) disposition of selenium (Se) during a phase I study of CPT-11 in combination with selenomethionine (SLM) in patients with advanced solid tumors

Authors :: Joshua Prey
Lakshmi Pendyala
Patrick F. Smith
P. Creaven
M. Murphy
Marwan Fakih
Y. M. Rustum
Source :: European Journal of Cancer Supplements. 2:156
Publication Year :: 2004
Publisher :: Elsevier BV, 2004.

Subjects :: Irinotecan
Cancer Research
Oncology
Pharmacokinetics
Chemistry
medicine
chemistry.chemical_element
In patient
Disposition
Pharmacology
Selenium
medicine.drug
Phase i study

Full Text Access

Tools